Mode
Text Size
Log in / Sign up
N/A N=102 Randomized Single-blind Other

Increasing the Temporal Window in Individuals With Alcohol Use Disorder

Alcohol Use Disorder

Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Jan 2026
Primary outcome: Primary: Delay Discounting (DD) Rates (Studies 1 and 2) — -5.33; -6.03; -4.94; -5.79 ln(K-value)

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Episodic Future Thinking (Behavioral); Control Episodic Thinking (Behavioral)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Virginia Polytechnic Institute and State University
Primary completion
Aug 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Delay Discounting (DD) Rates (Studies 1 and 2)
-5.33; -6.03; -4.94; -5.79; -6.72; -5.94
PRIMARY
Intensity of Alcohol Demand (Study 2)
11.19; 15.04; 11.22; 14.27; 10.87; 14.65
PRIMARY
In-Laboratory Alcohol Consumption (Study 1)
4.81; 5.25
PRIMARY
fMRI Hyper-connectivity Decrease During Delay Discounting (Study 1)
14; 0
PRIMARY
fMRI Hyper-connectivity Decrease During Alcohol Purchase Task (Study 1)
0; 0
PRIMARY
Change in Alcoholic Drinks Per Day (Study 2)
5.6; 5.3; 5.0; 4.9; 4.3; 5.4

Summary

Episodic future thinking (EFT) is based on the new science of prospection, which was first identified in a Science publication in 2007 and refers to pre-experiencing the future by simulation. Considerable evidence suggests that prospection is important for understanding human cognition, affect, motivation, and action. Individuals with damaged frontal areas, as well as individuals with alcohol use disorder (AUD), show deficits in planning prospectively. One systematic method to engender prospection is via EFT. EFT, as applied in our prior studies and in this proposal consists of having participants develop positive plausible future events that correspond to several future time frames (e.g., 2 weeks, 1 month, 3 months etc). For each of these timeframes participants are asked to concretize the events (e.g., What are you doing? Who will be there? What will you see, hear, smell, and feel?). We and others have used EFT to decrease delay discounting (DD) in individuals with AUD and smokers, as well as normal weight, overweight, and obese populations when compared to the control condition, control episodic thinking (CET). Consistent with reinforcer pathology, EFT also reduces alcohol valuation in the purchase task among individuals with AUD. However, no study to date has examined whether EFT reduces alcohol self-administration in the laboratory. Moreover, the neural correlates of EFT in AUD are also unknown. In these studies, we propose to test an intervention, EFT, which we hypothesize will decrease reinforcer pathology measures in a bar-like setting in the laboratory; that is, EFT will decrease delay discounting, as well as alcohol self-administration, demand, and craving compared to a control episodic thinking (CET) condition. Moreover, we hypothesize EFT will enhance activation in brain regions associated with prospection (e.g., hippocampus and amygdala) and the executive decision system (e.g., DLPFC). We will also examine the effect of EFT on real-world drinking.

Eligibility Criteria

Inclusion Criteria

  • High-risk or harmful drinking (measured by AUDIT)
  • 21-65 years of age
  • Desire to quit or cut down on their drinking, but do not have proximate plans to enroll in treatment for AUD during the study period
  • Report as one of their top three preferred drinks a beverage appropriate for the alcohol self-administration task (Study 1)

Exclusion Criteria

  • Moderate to severe DSM-5 criteria for substance-use disorders other than alcohol, nicotine, and/or marijuana
  • Current diagnosis of any psychotic disorder
  • History of seizure disorders or traumatic brain injury
  • Contraindication for participation in the self-administration (Study 1) or MRI sessions (Studies 1 and 2)
  • Current pregnancy or lactation.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04125238). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search